United States · Seed startup

Who invested in Aclid

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$3.3Mraised across 1 round since 2023, from 1 source

Latest round
Seed, $3.3MJun 2023
Investors
1
See who backed them

The rounds

  1. Jun 2023
    Seed$3.3M

    Source recorded

Founders and team

From Aclid's own website and the SEC filings it signed: 1 founder, 1 on the team.

Kevin FlyangoltsCEO & FounderNamed on its 2024 Form D
  • Lonnie RosenbaumVP Of Product

On the board, as filediAlex Iskold

AdvisersChad MolesNeeraj Rao

Everyone who backed them

2048 VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Aclid as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Coalition OperatorsVC firmPer its own site
Mute VenturesVC firmPer its own site

Quick answers about Aclid

Who invested in Aclid?

Aclid's investors include 2048 Ventures.

How much has Aclid raised?

Aclid has raised $3.3M across 1 round since 2023.

When did Aclid last raise?

Aclid's most recent round was a Seed of $3.3M in Jun 2023.

What was Aclid's biggest round?

Its most recent round, $3.3M in Jun 2023, is also its largest on record.

Who backed Aclid first?

Aclid's first round on record, in Jun 2023, was backed by 2048 Ventures.

What stage is Aclid at?

Aclid's latest named round is a Seed, in Jun 2023.

Where is Aclid based?

Aclid is based in the United States.

Companies like Aclid

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.